Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
499 | 3312 | 36.4 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHOLECYSTOKININ | Author keyword | 116 | 21% | 15% | 491 |
2 | L 365 260 | Author keyword | 79 | 69% | 2% | 68 |
3 | CCKB RECEPTOR | Author keyword | 53 | 79% | 1% | 34 |
4 | DEVAZEPIDE | Author keyword | 36 | 47% | 2% | 57 |
5 | CCK 8S | Author keyword | 31 | 74% | 1% | 23 |
6 | CCK 4 | Author keyword | 31 | 56% | 1% | 38 |
7 | CCK1 | Author keyword | 31 | 92% | 0% | 12 |
8 | CCK B RECEPTOR | Author keyword | 30 | 68% | 1% | 27 |
9 | CCK B RECEPTORS | Author keyword | 30 | 84% | 0% | 16 |
10 | CCK | Author keyword | 27 | 21% | 3% | 111 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHOLECYSTOKININ | 116 | 21% | 15% | 491 | Search CHOLECYSTOKININ | Search CHOLECYSTOKININ |
2 | L 365 260 | 79 | 69% | 2% | 68 | Search L+365+260 | Search L+365+260 |
3 | CCKB RECEPTOR | 53 | 79% | 1% | 34 | Search CCKB+RECEPTOR | Search CCKB+RECEPTOR |
4 | DEVAZEPIDE | 36 | 47% | 2% | 57 | Search DEVAZEPIDE | Search DEVAZEPIDE |
5 | CCK 8S | 31 | 74% | 1% | 23 | Search CCK+8S | Search CCK+8S |
6 | CCK 4 | 31 | 56% | 1% | 38 | Search CCK+4 | Search CCK+4 |
7 | CCK1 | 31 | 92% | 0% | 12 | Search CCK1 | Search CCK1 |
8 | CCK B RECEPTOR | 30 | 68% | 1% | 27 | Search CCK+B+RECEPTOR | Search CCK+B+RECEPTOR |
9 | CCK B RECEPTORS | 30 | 84% | 0% | 16 | Search CCK+B+RECEPTORS | Search CCK+B+RECEPTORS |
10 | CCK | 27 | 21% | 3% | 111 | Search CCK | Search CCK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | L 365 260 | 186 | 77% | 4% | 128 |
2 | OCTAPEPTIDE CCK 8 | 89 | 90% | 1% | 38 |
3 | POSTERIOR NUCLEUS ACCUMBENS | 77 | 96% | 1% | 24 |
4 | CCK | 74 | 32% | 6% | 190 |
5 | OCTAPEPTIDE | 64 | 38% | 4% | 133 |
6 | CCK RECEPTORS | 41 | 54% | 2% | 52 |
7 | B RECEPTOR | 38 | 23% | 4% | 142 |
8 | GASTRIN RECEPTOR | 36 | 51% | 2% | 50 |
9 | CHOLECYSTOKININ RECEPTORS | 35 | 35% | 2% | 79 |
10 | PEPTIDE MONOAMINE COEXISTENCE | 31 | 92% | 0% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
BIOLOGICAL ACTIONS OF CHOLECYSTOKININ | 1994 | 532 | 439 | 67% |
International union of pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors | 1999 | 278 | 373 | 76% |
Cholecystokinin antagonists: Pharmacological and therapeutic potential | 2003 | 109 | 246 | 77% |
NEURONAL NETWORK OF PANIC DISORDER: THE ROLE OF THE NEUROPEPTIDE CHOLECYSTOKININ | 2012 | 14 | 170 | 68% |
CCK in anxiety and cognitive processes | 1998 | 90 | 119 | 85% |
CHOLECYSTOKININ RECEPTORS | 1995 | 251 | 200 | 37% |
Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models | 2003 | 60 | 122 | 75% |
Cholecystokinin in anxiety | 1996 | 86 | 124 | 76% |
CHOLECYSTOKININ-DOPAMINE INTERACTIONS | 1991 | 236 | 41 | 93% |
CCK-B receptor: Chemistry, molecular biology, biochemistry and pharmacology | 1999 | 112 | 253 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOL DRUG DYNAM | 6 | 80% | 0.1% | 4 |
2 | ENVIRONM ECOSYST | 3 | 50% | 0.1% | 4 |
3 | PHARMACOCHIM MOL STRUCT | 3 | 14% | 0.5% | 18 |
4 | PHARMACOL PAIN | 3 | 32% | 0.2% | 7 |
5 | UNITE 531 | 2 | 67% | 0.1% | 2 |
6 | U151 | 2 | 30% | 0.2% | 6 |
7 | MODELISAT PL CHIM | 2 | 50% | 0.1% | 3 |
8 | INSERMU266 | 2 | 22% | 0.2% | 7 |
9 | COMBAT CARE PERFORMANCE | 2 | 43% | 0.1% | 3 |
10 | HEBEI FORENS MED | 2 | 17% | 0.3% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000181871 | INDEPENDENT INGESTION//DEVAZEPIDE//A 70104 |
2 | 0.0000103643 | PROGASTRIN//GASTRIN//GLYCINE EXTENDED GASTRIN |
3 | 0.0000099926 | PANCREATIC SECRETION//BILE PANCREATIC JUICE DIVERSION//CCK 58 |
4 | 0.0000078763 | SDT FATTY RAT//SDT RAT//PLANNING DEV SECT |
5 | 0.0000072796 | PANCREATIC ACINI//AMYLASE SECRETION//JMV 180 |
6 | 0.0000062837 | PEPSINOGEN SECRETION//GASTRIC MUCIN SECRETION//NAKAHARI PROJECT |
7 | 0.0000054704 | KEMEROVO SCI//04KA//ADD ORGAN OPERAT |
8 | 0.0000036071 | BETA ENDORPHIN FRAGMENTS//DESENKEPHALIN GAMMA ENDORPHIN//IMPULSE DYSCONTROL |
9 | 0.0000034244 | NOR BINALTORPHAMINE//MINNESOTA OBES//NEUROPSYCHOL DOCTORAL SUB PROGRAM |
10 | 0.0000033289 | ENTEROCHROMAFFIN LIKE CELLS//ECL CELL//ENTEROCHROMAFFIN LIKE CELL |